61 results
Page 3 of 4
425
EX-10.1
jb3vp
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.1
8vv4b5un8yx0
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
67a6s
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-99.1
4s829vf4s v0owffw
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm
424B3
i6hv033 1wt51am
3 May 13
Prospectus supplement
12:00am
DEF 14A
d8lg5bvf4m1
26 Apr 13
Definitive proxy
12:00am
10-12G
EX-10.8
nbp9j
11 Apr 12
Registration of securities
12:00am
10-12G
EX-10.9
qwqsbzl8y3j
11 Apr 12
Registration of securities
12:00am
10-12G
EX-10.17
u7xwr3lqeas2ka
11 Apr 12
Registration of securities
12:00am
10-12G
EX-10.18
r18x0yqxx af7
11 Apr 12
Registration of securities
12:00am
10-12G
EX-10.21
ldl2nh8
11 Apr 12
Registration of securities
12:00am
10-12G
EX-10.10
xvj7niflk2vrs
11 Apr 12
Registration of securities
12:00am
10-12G
EX-10.22
x5ha1n l4ed7
11 Apr 12
Registration of securities
12:00am